FACULTY & STAFF DIRECTORY
ADDITIONAL CONTACT INFORMATION
EDUCATION
RESEARCH INTERESTS
COLLABORATORSM.O. Landázuri (HUP, Madrid, ES) J. Guinovart (IRB, Barcelona, ES) P.S. Yan (Columbus U., Ohio, US) Z. Trajanoski (U of Tech, Graz, AU) L. Montoliu (CNB; Madrid, ES) J.L Gomez-Skarmeta (CABD, Sevilla, ES) B. Jimenez (UAM, Madrid,ES) A. Harris (U. Oxford, Oxford, UK) W.W. Wasserman (UBC, Vancouver, CA)PROFESSIONAL ACTIVITIES
PublicationsJournal Articles1 Martinez-Poveda B, Gomez V, Alcaide-German M, Perruca S, Vazquez S, Alba LE, Casanovas O, Garcia-Bermejo ML, Peso L, Jimenez B. Non-invasive monitoring of hypoxia-inducible factor activation by optical imaging during antiangiogenic treatment in a xenograft model of ovarian carcinoma. Int. J. Oncol. 39(3):543-52. (2011) PMID 21667025 2 Pescador N, Villar D, Cifuentes D, Garcia-Rocha M, Ortiz-Barahona A, Vazquez S, Ordoñez A, Cuevas Y, Saez-Morales D, Garcia-Bermejo ML, Landazuri MO, Guinovart J, del Peso L. Hypoxia promotes glycogen accumulation through hypoxia inducible factor (HIF)-mediated induction of glycogen synthase 1. PLoS ONE 5(3):e9644. (2010) PMID 20300197 3 Ortiz-Barahona A, Villar D, Pescador N, Amigo J, del Peso L. Genome-wide identification of hypoxia-inducible factor binding sites and target genes by a probabilistic model integrating transcription-profiling data and in silico binding site prediction. Nucleic Acids Res. 38(7):2332-45. (2010) PMID 20061373 4 Aceves-Luquero CI, Agarwal A, Callejas-Valera JL, Arias-González L, Esparís-Ogando A, del Peso Ovalle L, Bellón-Echeverria I, de la Cruz-Morcillo MA, Galán Moya EM, Moreno Gimeno I, Gómez JC, Deininger MW, Pandiella A, Sánchez Prieto R. ERK2, but not ERK1, mediates acquired and "de novo" resistance to imatinib mesylate: implication for CML therapy. PLoS ONE 4(7):e6124. (2009) PMID 19568437 5 Alcaide-German ML, Vara-Vega A, Garcia-Fernandez LF, Landazuri MO, del Peso L. A yeast three-hybrid system that reconstitutes mammalian hypoxia inducible factor regulatory machinery. BMC Cell Biol. 9:18. (2008) PMID 18402654 6 Villar D, Vara-Vega A, Landázuri MO, Del Peso L. Identification of a region on hypoxia-inducible-factor prolyl 4-hydroxylases that determines their specificity for the oxygen degradation domains. Biochem. J. 408(2):231-40. (2007) PMID 17725546 7 Olmos G, Conde I, Arenas I, Del Peso L, Castellanos C, Landazuri MO, Lucio-Cazana J. Accumulation of hypoxia-inducible factor-1alpha through a novel electrophilic, thiol antioxidant-sensitive mechanism. Cell. Signal. 19(10):2098-105. (2007) PMID 17658243 8 Calzada MJ, del Peso L. Hypoxia-inducible factors and cancer. Clin Transl Oncol 9(5):278-89. (2007) PMID 17525038 9 Landázuri MO, Vara-Vega A, Vitón M, Cuevas Y, del Peso L. Analysis of HIF-prolyl hydroxylases binding to substrates. Biochem. Biophys. Res. Commun. 351(2):313-20. (2006) PMID 17069766 10 Pescador N, Cuevas Y, Naranjo S, Alcaide M, Villar D, Landázuri MO, Del Peso L. Identification of a functional hypoxia-responsive element that regulates the expression of the egl nine homologue 3 (egln3/phd3) gene. Biochem. J. 390(Pt 1):189-97. (2005) PMID 15823097 11 Cuevas Y, Hernández-Alcoceba R, Aragones J, Naranjo-Suárez S, Castellanos MC, Esteban MA, Martín-Puig S, Landazuri MO, del Peso L. Specific oncolytic effect of a new hypoxia-inducible factor-dependent replicative adenovirus on von Hippel-Lindau-defective renal cell carcinomas. Cancer Res. 63(20):6877-84. (2003) PMID 14583486 12 del Peso L, Castellanos MC, Temes E, Martin-Puig S, Cuevas Y, Olmos G, Landazuri MO. The von Hippel Lindau/hypoxia-inducible factor (HIF) pathway regulates the transcription of the HIF-proline hydroxylase genes in response to low oxygen. J. Biol. Chem. 278(49):48690-5. (2003) PMID 14506252 13 Naranjo-Suárez S, Castellanos MC, Alvarez-Tejado M, Vara A, Landázuri MO, del Peso L. Down-regulation of hypoxia-inducible factor-2 in PC12 cells by nerve growth factor stimulation. J. Biol. Chem. 278(34):31895-901. (2003) PMID 12805361 14 Lucas L, Penalva V, Ramírez de Molina A, Del Peso L, Lacal JC. Modulation of phospholipase D by Ras proteins mediated by its effectors Ral-GDS, PI3K and Raf-1. Int. J. Oncol. 21(3):477-85. (2002) PMID 12168089 15 Alvarez-Tejado M, Alfranca A, Aragonés J, Vara A, Landázuri MO, del Peso L. Lack of evidence for the involvement of the phosphoinositide 3-kinase/Akt pathway in the activation of hypoxia-inducible factors by low oxygen tension. J. Biol. Chem. 277(16):13508-17. (2002) PMID 11815624 16 Alvarez-Tejado M, Naranjo-Suarez S, Jiménez C, Carrera AC, Landázuri MO, del Peso L. Hypoxia induces the activation of the phosphatidylinositol 3-kinase/Akt cell survival pathway in PC12 cells: protective role in apoptosis. J. Biol. Chem. 276(25):22368-74. (2001) PMID 11294857 17 Hernández-Alcoceba R, del Peso L, Lacal JC. The Ras family of GTPases in cancer cell invasion. Cell. Mol. Life Sci. 57(1):65-76. (2000) PMID 10949581 18 Inohara N, Koseki T, Lin J, del Peso L, Lucas PC, Chen FF, Ogura Y, Núñez G. An induced proximity model for NF-kappa B activation in the Nod1/RICK and RIP signaling pathways. J. Biol. Chem. 275(36):27823-31. (2000) PMID 10880512 19 del Peso L, Gonzalez VM, Inohara N, Ellis RE, Núñez G. Disruption of the CED-9.CED-4 complex by EGL-1 is a critical step for programmed cell death in Caenorhabditis elegans. J. Biol. Chem. 275(35):27205-11. (2000) PMID 10846174 20 Lucas L, del Peso L, Rodríguez P, Penalva V, Lacal JC. Ras protein is involved in the physiological regulation of phospholipase D by platelet derived growth factor. Oncogene 19(3):431-7. (2000) PMID 10656691 21 del Peso L, González VM, Hernández R, Barr FG, Núñez G. Regulation of the forkhead transcription factor FKHR, but not the PAX3-FKHR fusion protein, by the serine/threonine kinase Akt. Oncogene 18(51):7328-33. (1999) PMID 10602488 22 Inohara N, Koseki T, del Peso L, Hu Y, Yee C, Chen S, Carrio R, Merino J, Liu D, Ni J, Núñez G. Nod1, an Apaf-1-like activator of caspase-9 and nuclear factor-kappaB. J. Biol. Chem. 274(21):14560-7. (1999) PMID 10329646 23 del Peso L, González VM, Núñez G. Caenorhabditis elegans EGL-1 disrupts the interaction of CED-9 with CED-4 and promotes CED-3 activation. J. Biol. Chem. 273(50):33495-500. (1998) PMID 9837929 24 Nuñez G, del Peso L. Linking extracellular survival signals and the apoptotic machinery. Curr. Opin. Neurobiol. 8(5):613-8. (1998) PMID 9811624 25 Esteve P, Embade N, Perona R, Jiménez B, del Peso L, León J, Arends M, Miki T, Lacal JC. Rho-regulated signals induce apoptosis in vitro and in vivo by a p53-independent, but Bcl2 dependent pathway. Oncogene 17(14):1855-69. (1998) PMID 9778052 26 Inohara N, del Peso L, Koseki T, Chen S, Núñez G. RICK, a novel protein kinase containing a caspase recruitment domain, interacts with CLARP and regulates CD95-mediated apoptosis. J. Biol. Chem. 273(20):12296-300. (1998) PMID 9575181 27 del Peso L, Hernández-Alcoceba R, Embade N, Carnero A, Esteve P, Paje C, Lacal JC. Rho proteins induce metastatic properties in vivo. Oncogene 15(25):3047-57. (1997) PMID 9444953 28 del Peso L, González-García M, Page C, Herrera R, Nuñez G. Interleukin-3-induced phosphorylation of BAD through the protein kinase Akt. Science 278(5338):687-9. (1997) PMID 9381178 29 del Peso L, Lucas L, Esteve P, Lacal JC. Activation of phospholipase D by growth factors and oncogenes in murine fibroblasts follow alternative but cross-talking pathways. Biochem. J. 322 ( Pt 2):519-28. (1997) PMID 9065772 30 del Peso L, Hernández R, Esteve P, Lacal JC. Activation of phospholipase D by ras proteins is independent of protein kinase C. J. Cell. Biochem. 61(4):599-608. (1996) PMID 8806084 31 Esteve P, del Peso L, Lacal JC. Induction of apoptosis by rho in NIH 3T3 cells requires two complementary signals. Ceramides function as a progression factor for apoptosis. Oncogene 11(12):2657-65. (1995) PMID 8545123 32 Jiménez B, del Peso L, Montaner S, Esteve P, Lacal JC. Generation of phosphorylcholine as an essential event in the activation of Raf-1 and MAP-kinases in growth factors-induced mitogenic stimulation. J. Cell. Biochem. 57(1):141-9. (1995) PMID 7721953 33 Carnero A, Cuadrado A, del Peso L, Lacal JC. Activation of type D phospholipase by serum stimulation and ras-induced transformation in NIH3T3 cells. Oncogene 9(5):1387-95. (1994) PMID 8152799
|